Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Mark, Wasley"'
Autor:
James Welsh, Vittorio Cristini, Mark Wasley, Joylise Mitchell, Nahum Puebla-Osorio, Ailing Huang, Sara Nizzero, Gitika Srivastava, Thomas Riad, Papa Diogop Ndiaye, Mariam Gachechiladze, Philipp Oertle, Tobias Appenzeller, Marko Loparic, Marija Plodinec
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/68c3759873d84ba0a9b2e01d1e691d6a
Autor:
Yun Hu, Sébastien Paris, Genevieve Bertolet, Hampartsoum B. Barsoumian, Kewen He, Duygu Sezen, Dawei Chen, Mark Wasley, Jordan DA SILVA, Joylise A. Mitchell, Tiffany A. Voss, Fatemeh Masrorpour, Claudia Kettlun Leyton, Liangpeng Yang, Carola Leuschner, Nahum Puebla-Osorio, Saumil Gandhi, Quynh-Nhu Nguyen, Maria Angelica Cortez, James W. Welsh
Publikováno v:
Journal of Nanobiotechnology, Vol 20, Iss 1, Pp 1-19 (2022)
Abstract Background While improvements in immunoradiotherapy have significantly improved outcomes for cancer patients, this treatment approach has nevertheless proven ineffective at controlling the majority of malignancies. One of the mechanisms of r
Externí odkaz:
https://doaj.org/article/a090d791bef0465c93bf5eb25e2451f7
Autor:
Yun Hu, Sébastien Paris, Hampartsoum Barsoumian, Chike O. Abana, Kewen He, Duygu Sezen, Mark Wasley, Fatemeh Masrorpour, Dawei Chen, Liangpeng Yang, Joe D. Dunn, Saumil Gandhi, Quynh-Nhu Nguyen, Maria Angelica Cortez, James W. Welsh
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-14 (2021)
Abstract Background Combining radiotherapy with PD1 blockade has had impressive antitumor effects in preclinical models of metastatic lung cancer, although anti-PD1 resistance remains problematic. Here, we report results from a triple-combination the
Externí odkaz:
https://doaj.org/article/07dc075fcbd049008b2e635b70dfaf0b
Autor:
Duygu Sezen, Hampartsoum B. Barsoumian, Kewen He, Yun Hu, Qi Wang, Chike O. Abana, Nahum Puebla-Osorio, Ethan Y. Hsu, Mark Wasley, Fatemeh Masrorpour, Jing Wang, Maria Angelica Cortez, James W. Welsh
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Radiation therapy (XRT) has a well-established role in cancer treatment. Given the encouraging results on immunostimulatory effects, radiation has been increasingly used with immune-check-point inhibitors in metastatic disease, especially when immuno
Externí odkaz:
https://doaj.org/article/20ba2088e44043fcbe418952fcb64974
Autor:
James Welsh, Sébastien Paris, Hampartsoum Barsoumian, Yun Hu, Mark Wasley, Liangpeng Yang, Quynh-Nhu Nguyen, Fatemeh Masrorpour, Saumil Gandhi, Genevieve Bertolet, Lily Schuda, Kewen He, Duygu Sezen, Joylise Mitchell, Tiffany Voss, SILVA Jordan, Claudia Kettlun Leyton, Nahum Puebla-Osorio, Angelica Cortez
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/ac4c8f454ce64995a234fdcb51a58ba6
Autor:
Ahmed I. Younes, Hampartsoum B. Barsoumian, Duygu Sezen, Vivek Verma, Roshal Patel, Mark Wasley, Yun Hu, Joe D. Dunn, Kewen He, Dawei Chen, Hari Menon, Fatemeh Masrorpour, Meidi Gu, Liangpeng Yang, Nahum Puebla-Osorio, Maria Angelica Cortez, James W. Welsh
Publikováno v:
Translational Oncology, Vol 14, Iss 2, Pp 100983- (2021)
Radiotherapy (RT) has been used to control tumors by physically damaging DNA and inducing apoptosis; it also promotes antitumor immune responses via neoantigens release and augmenting immune-oncology agents to elicit systemic response. Tumor regressi
Externí odkaz:
https://doaj.org/article/804f3de3e7644ceb9a234f76d8d52b61
Autor:
James Welsh, Hari Menon, Dawei Chen, Rishab Ramapriyan, Vivek Verma, Maria Angelica Cortez, Chunxiao Guo, Hampartsoum Barsoumian, Ahmed Younes, Yun Hu, Mark Wasley
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background This study compared response rates and outcomes of combined radiotherapy and immunotherapy (iRT) based on the type of checkpoint inhibitor (anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4) vs antiprogrammed death-1 (PD1)) for metas
Externí odkaz:
https://doaj.org/article/234e2a69d0af4182b9b53262ae2884fe
Autor:
James W. Welsh, Maria Angelica Cortez, Katherine Klein, Tugce Ozgen, Sara Mosaffa, Fatemeh Masropour, Mark Wasley, Hari Menon, Yun Hu, Vivek Verma, Ahmed I. Younes, Liangpeng Yang, Hampartsoum B. Barsoumian, Dawei Chen
Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f95625e3541384be46a8ffa61c5569c
https://doi.org/10.1158/2326-6066.22543947
https://doi.org/10.1158/2326-6066.22543947
Autor:
James W. Welsh, Maria Angelica Cortez, Katherine Klein, Tugce Ozgen, Sara Mosaffa, Fatemeh Masropour, Mark Wasley, Hari Menon, Yun Hu, Vivek Verma, Ahmed I. Younes, Liangpeng Yang, Hampartsoum B. Barsoumian, Dawei Chen
Immune checkpoint inhibitors, such as anti–PD-1/PD-L1, have emerged as promising therapies for advanced non–small cell lung cancer (NSCLC). However, approximately 80% of patients do not respond to immunotherapy given alone because of intrinsic or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cda51812534a46937fc87a65c71cbc67
https://doi.org/10.1158/2326-6066.c.6550473
https://doi.org/10.1158/2326-6066.c.6550473
Autor:
Yun Hu, Sébastien Paris, Genevieve Bertolet, Hampartsoum Barsoumian, Kewen He, Duygu Sezen, Dawei Chen, Mark Wasley, Jordan DA SILVA, Joylise A Mitchell, Tiffany A Voss, Fatemeh Masrorpour, Claudia Kettlun Leyton, Liangpeng Yang, Carola Leuschner, Nahum Puebla-Osorio, Saumil Gandhi, Quynh-Nhu Nguyen, Maria Angelica Cortez, James W. Welsh
Background: While improvements in radioimmunotherapy have made significant headway in improving outcomes for cancer patients, this treatment approach has nevertheless proven ineffective at controlling the majority of malignancies. One of the mechanis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d809078015ea6207acaa12126d68a804
https://doi.org/10.21203/rs.3.rs-1627514/v1
https://doi.org/10.21203/rs.3.rs-1627514/v1